Fauerholdt L, Schlichting P, Christensen E, Poulsen H, Tygstrup N, Juhl E
Hepatology. 1983 Nov-Dec;3(6):928-31. doi: 10.1002/hep.1840030607.
The conversion from micro- to macronodular cirrhosis is claimed to be a general phenomenon. In this study, the conversion was quantitated by means of liver needle follow-up biopsies and autopsy in 156 patients followed in a controlled clinical trial of prednisone treatment in cirrhosis. In the initial biopsy, 75 patients were classified as micronodular cirrhosis, and of them, 68 had macronodular cirrhosis at autopsy indicating a conversion ratio of about 0.9 in 10 years. This may overestimate the true conversion ratio slightly since conversion in many cases only was demonstrated at autopsy where the diagnosis of macronodular cirrhosis is made with greater certainty than from a needle biopsy. The median time interval between the diagnosis of micro- and macronodular cirrhosis was 2.25 years which is a maximum estimate of the conversion time due to irregular spacing between biopsies (or biopsy and autopsy). No significant difference was found between the conversion time in females and males. The conversion was faster in patients not drinking alcohol compared to patients drinking alcohol, but the difference was not significant. Prednisone treatment tended to accelerate the conversion, but not significantly.
从小结节性肝硬化向大结节性肝硬化的转变被认为是一种普遍现象。在本研究中,通过肝穿刺随访活检和尸检对156例在肝硬化泼尼松治疗对照临床试验中接受随访的患者的这种转变进行了定量分析。在初次活检时,75例患者被归类为小结节性肝硬化,其中68例在尸检时为大结节性肝硬化,表明10年的转变率约为0.9。这可能会稍微高估真实的转变率,因为在许多情况下,只有在尸检时才证实了转变,而在尸检时对大结节性肝硬化的诊断比肝穿刺活检更确定。小结节性肝硬化和大结节性肝硬化诊断之间的中位时间间隔为2.25年,这是由于活检(或活检与尸检)之间间隔不规则而对转变时间的最大估计。女性和男性的转变时间没有显著差异。与饮酒患者相比,不饮酒患者的转变更快,但差异不显著。泼尼松治疗倾向于加速这种转变,但不显著。